Fertility preservation in male adolescents with cancer (2011–2020): A retrospective study in China
Shasha Liu,Qiling Wang,Wenbing Zhu,Zhou Zhang,Wenhao Tang,Huiqiang Sheng,Jigao Yang,Yushan Li,Xiaowei Liang,Tianqing Meng,Zhiqiang Wang,Faxi Lin,Hao Dong,Xiaojin He,Xianglong Jiang,Shanjun Dai,Aiping Zhang,Chunying Song,Zuowen Liang,Feng Zhang,Xiaojun Wang,Peiyu Liang,Guihua Gong,Xiaohong Huai,Yanyun Wang,Fuping Li,Xinzong Zhang
DOI: https://doi.org/10.1002/cam4.7354
IF: 4.711
2024-06-15
Cancer Medicine
Abstract:Background According to the studies, more than 80% of pediatric patients with cancer can achieve a survival rate greater than 5 years; however, long‐term chemotherapy and/or radiation therapy may seriously affect their reproductive ability. Fertility preservation in adolescents with cancer in China was initiated late, and related research is lacking. Analyze data to understand the current situation and implement measures to improve current practices. Methods From 2011 to 2020, data on 275 male adolescents with cancer whose age ranged from 0 to 19 years old were collected from 16 human sperm banks for this retrospective study. Methods include comparing the basic situation of male adolescents with cancer, the distribution of cancer types, and semen quality to analyze the status of fertility preservation. Results The mean age was 17.39 ± 1.46 years, with 13 cases (4.7%) aged 13–14 years and 262 cases (95.3%) aged 15–19 years. Basic diagnoses included leukemia (55 patients), lymphomas (76), germ cell and gonadal tumors (65), epithelial tumors (37), soft tissue sarcomas (14), osteosarcoma (7), brain tumors (5), and other cancers (16). There are differences in tumor types in different age stages and regions. The tumor type often affects semen quality, while age affects semen volume. Significant differences were found in sperm concentration and progressive motility before and after treatment (p
oncology